Provectus Pharmaceuticals Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Provectus Pharmaceuticals Inc.

PVCT 0.0515

-26.1%

3:58 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Howard Williams who wrote (11509)	9/21/2012 7:19:02 AM
From: NTTG	Read Replies (1) of 13111

Smart move by Pfizer to protect their sunitinib interest. FDA clearly signaling to PVCT that the next step liver trial will need to be a combination therapy protocol with Pfizer's drug (they dont trust PV-10 alone?), PVCT has probably approach Pfizer for free drug for the planned trial, low risk for Pfizer at this point.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next